These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 17073837

  • 21. Clinical trial: healing of NSAID-associated gastric ulcers in patients continuing NSAID therapy - a randomized study comparing ranitidine with esomeprazole.
    Goldstein JL, Johanson JF, Hawkey CJ, Suchower LJ, Brown KA.
    Aliment Pharmacol Ther; 2007 Oct 15; 26(8):1101-11. PubMed ID: 17894652
    [Abstract] [Full Text] [Related]

  • 22. Ranitidine in the treatment of non-steroidal anti-inflammatory drug associated gastric and duodenal ulcers.
    Lancaster-Smith MJ, Jaderberg ME, Jackson DA.
    Gut; 1991 Mar 15; 32(3):252-5. PubMed ID: 2013419
    [Abstract] [Full Text] [Related]

  • 23. Peptic ulcer therapy with lansoprazole and Helicobacter pylori eradication.
    Ogoshi K, Kato T, Sakagawa T.
    J Clin Gastroenterol; 1995 Mar 15; 20 Suppl 2():S97-9. PubMed ID: 7594354
    [Abstract] [Full Text] [Related]

  • 24. Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhibitors lansoprazole, rabeprazole, and pantoprazole compared with omeprazole, ranitidine, and placebo: evidence from randomized clinical trials.
    Caro JJ, Salas M, Ward A.
    Clin Ther; 2001 Jul 15; 23(7):998-1017. PubMed ID: 11519776
    [Abstract] [Full Text] [Related]

  • 25. Omeprazole and sucralfate in the treatment of NSAID-induced gastric and duodenal ulcer.
    Bianchi Porro G, Lazzaroni M, Manzionna G, Petrillo M.
    Aliment Pharmacol Ther; 1998 Apr 15; 12(4):355-60. PubMed ID: 9690725
    [Abstract] [Full Text] [Related]

  • 26. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
    Lai KC, Chu KM, Hui WM, Wong BC, Hu WH, Wong WM, Chan AO, Wong J, Lam SK.
    Am J Med; 2005 Nov 15; 118(11):1271-8. PubMed ID: 16271912
    [Abstract] [Full Text] [Related]

  • 27. Therapies for ulcers associated with nonsteroidal antiinflammatory drugs.
    DeMarco PJ, Schulman S, Shikhman AR.
    N Engl J Med; 1998 Jul 30; 339(5):350-1. PubMed ID: 9696652
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Therapies for ulcers associated with nonsteroidal antiinflammatory drugs.
    Chan FK, Sung JJ.
    N Engl J Med; 1998 Jul 30; 339(5):349-50; author reply 350-1. PubMed ID: 9696650
    [No Abstract] [Full Text] [Related]

  • 31. Management of nonsteroidal anti-inflammatory drug-associated lesions: a cost-effectiveness perspective.
    Jönsson B, Wahlqvist P.
    Am J Med; 1998 Mar 30; 104(3A):81S-88S. PubMed ID: 9572326
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Gastro-duodenal protection in an era of cyclo-oxygenase-2-selective nonsteroidal anti-inflammatory drugs.
    Naesdal J, Wilson I.
    Eur J Gastroenterol Hepatol; 2001 Dec 30; 13(12):1401-6. PubMed ID: 11742186
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Peptic ulcer therapy with cimetidine versus tripotassium dicitrato bismuthate in rheumatoid arthritis patients undergoing chronic NSAID treatment.
    Bianchi Porro G, Lazzaroni M, Petrillo M, Ardizzone S, Manzionna G, Caruso I, Montrone F.
    Aliment Pharmacol Ther; 1998 Apr 30; 12(4):343-7. PubMed ID: 9690723
    [Abstract] [Full Text] [Related]

  • 36. Ranitidine in the treatment of gastric and duodenal ulcers associated with non-steroidal anti-inflammatory drugs.
    Tildesley G, Ehsanullah RS, Wood JR.
    Br J Rheumatol; 1993 Jun 30; 32(6):474-8. PubMed ID: 8508283
    [Abstract] [Full Text] [Related]

  • 37. Secondary prevention of upper gastrointestinal bleeding associated with maintenance acid-suppressing treatment in patients with peptic ulcer bleed.
    García Rodríguez LA, Ruigómez A.
    Epidemiology; 1999 May 30; 10(3):228-32. PubMed ID: 10230829
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Appropriate choice of proton pump inhibitor therapy in the prevention and management of NSAID-related gastrointestinal damage.
    Singh G, Triadafilopoulos G.
    Int J Clin Pract; 2005 Oct 30; 59(10):1210-7. PubMed ID: 16178990
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.